In AML patients treated by allogeneic hematopoietic transplantation, CD34+supermobilization is a negative prognostic factor

被引：0
|
作者：
Avola, Giuseppe [1 ]
Camuglia, Maria Grazia [1 ]
Milone, Giuseppe [1 ]
机构：
[1] Azienda Osped Policlin Vittorio Emanuele, Programma Trapianto Emopoiet, I-95100 Catania, Italy
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷 / 07期
关键词：
ACUTE MYELOID-LEUKEMIA; PERIPHERAL-BLOOD; MOBILIZATION; RELAPSE; RISK;
D O I：
10.1016/j.leukres.2013.03.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：853 / 854
页数：2
相关论文
共 50 条
  • [21] Allogeneic Hematopoietic Cell Transplantation May Alleviate the Negative Prognostic Impact of Monosomal and Complex Karyotypes on Patients with Acute Myeloid Leukemia
    Guo, Robert J.
    Atenafu, Eshetu G.
    Craddock, Ken
    Chang, Hong
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (05) : 690 - 695
  • [22] Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation
    Tamari, Roni
    Oran, Betul
    Hilden, Patrick
    Maloy, Molly
    Kongtim, Piyanuch
    Papadopoulos, Esperanza B.
    Rondon, Gabriela
    Jakubowski, Ann A.
    Andersson, Borje S.
    Devlin, Sean M.
    Ahmed, Sairah
    Popat, Uday R.
    Ponce, Doris
    Chen, Julianne
    Sauter, Craig
    Young, James W.
    de Lima, Marcos
    Perales, Miguel-Angel
    O'Reilly, Richard J.
    Giralt, Sergio A.
    Champlin, Richard E.
    Castro-Malaspina, Hugo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (05) : 1079 - 1087
  • [23] Adverse impact of a high allelic burden FLT3-ITD mutation on allogeneic hematopoietic stem cell transplantation in patients with cytogenetically normal AML
    Wan, Li
    Ding, Shuqi
    Xu, Mimi
    Lv, Kangkang
    Du, Yuanyuan
    Wu, Depei
    Xu, Mingzhu
    Liu, Yuejun
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (05) : 731 - 743
  • [24] HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
    Roerden, Malte
    Nelde, Annika
    Heitmann, Jonas S.
    Klein, Reinhild
    Rammensee, Hans-Georg
    Bethge, Wolfgang A.
    Walz, Juliane S.
    CANCERS, 2020, 12 (07) : 1 - 10
  • [25] Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation
    Grimm, Juliane
    Jentzsch, Madlen
    Bill, Marius
    Goldmann, Karoline
    Schulz, Julia
    Niederwieser, Dietger
    Platzbecker, Uwe
    Schwind, Sebastian
    BLOOD ADVANCES, 2020, 4 (16) : 3864 - 3874
  • [26] Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute leukemia
    Konova, Z., V
    Parovichnikova, E. N.
    Galtseva, I., V
    Drokov, M. Yu
    Davydova, Yu O.
    Kapranov, N. M.
    Vasilyeva, V. A.
    Kuzmina, L. A.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (04): : 539 - 555
  • [27] Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients
    Hobbs, Gabriela Soriano
    Perales, Miguel-Angel
    JOURNAL OF CLINICAL MEDICINE, 2015, 4 (03): : 488 - 503
  • [28] Optimizing the CD34+cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation
    Mehta, Jayesh
    Frankfurt, Olga
    Altman, Jessica
    Evens, Andrew
    Tallman, Martin
    Gordon, Leo
    Williams, Stephanie
    Winter, Jane
    Krishnamurthy, Jairam
    Duffey, Sara
    Singh, Veerpal
    Meagher, Richard
    Grinblatt, David
    Kaminer, Lynne
    Singhal, Seema
    LEUKEMIA & LYMPHOMA, 2009, 50 (09) : 1434 - 1441
  • [29] CD34+chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation
    Unnikrishnan, Athira
    Meacham, Amy M.
    Goldstein, Steven S.
    Ta, Mai
    Leather, Helen L.
    Cogle, Christopher R.
    Castillo, Paul
    Wingard, John R.
    Norkin, Maxim
    LEUKEMIA RESEARCH, 2018, 74 : 110 - 112
  • [30] Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Backhaus, Donata
    Jentzsch, Madlen
    Bischof, Lara
    Brauer, Dominic
    Wilhelm, Christina
    Schulz, Julia
    Franke, Georg-Nikolaus
    Poenisch, Wolfram
    Vucinic, Vladan
    Platzbecker, Uwe
    Schwind, Sebastian
    CANCERS, 2021, 13 (22)
12345